Policy and Regulatory
Health Education England publishes NHS AI roadmap
The roadmap forms part of a report which aims to understand the use of AI and data-driven technologies that are currently being used in the NHS, the uptake of these technologies and the impact they are having on the staff using them.
NHS gene testing missing half of people at cancer risk
A study of 152 patients suggests that access to genetic testing should be made easier because the guidelines as drawn up “would have excluded many people who had ‘actionable’ genetic alterations that could raise their risk of cancer.
BÄK President proposes remuneration for doctors who test digitalisation projects
Renumeration could encourage more doctors to try out digitalisation as they feel compensated by it, suggests BAK President Klaus Reinhardt in a recent podcast.
CMS expands Medicare coverage for lung cancer screening
The announcement from Medicare shows that the agency is catching up to coverage already offered by private insurers.
CMS code seen as major step toward reimbursement for digital therapeutics
The CMS published a new Level II Healthcare Common Procedure Coding System (HCPCS) code for "prescription digital behavioral therapy," which could make it easier for commercial and Medicaid plans to cover these therapies. It will go into effect in April.
Dexcom G6 added to Australia's CGM subsidy
This comes as the previous version of the CGM device, Dexcom G5, is being phased out in the country by local distributor AMSL Diabetes due to international supply chain issues.
Initiatives and companies
GRAIL and Point32Health Collaborate to Offer Galleri® Multi-Cancer Early Detection Blood Test
GRAIL announced an agreement with Point32Health, the combined organization of Harvard Pilgrim Health Care and Tufts Health Plan, to collaborate on a two-phased pilot of Galleri®, GRAIL's groundbreaking multi-cancer early detection blood test.
PinPoint cancer diagnostic rolled out across Cheshire and Merseyside
The PinPoint Test analyses a blood sample using an artificial intelligence-based algorithm that will allow clinicians to identify patients both at high risk and at very low risk of developing cancer.
FDA Clears Credit-Card-Sized Personal EKG Device
FDA cleared AliveCor's KardiaMobile Card, which the Mountain View, CA-based company describes as "the slimmest, most convenient personal ECG device ever created."
How Abbott’s Newest Indication Is Reshaping Heart Failure Management
The wearable sensor provides a more convenient way of measuring pulmonary artery pressure, which could only be previously measured at a clinic.
Teladoc Health launches chronic care management program
Under the new offering, patients with diabetes, prediabetes and hypertension are provided connected devices like glucometers and blood pressure cuffs. They're also paired with personal health coaches.
Omada Health raises $192M in Series E funding and Verily’s Onduo snags a payer partners
Digital chronic disease player Omada Health will use funding to prevent high risk patients from developing complex conditions while a similar company Onduo is teaming up with US Payer Highmark Health to launch a diabetes programme.
ResApp's diagnostic app coming to Health Teams' aged care telehealth platform
The respiratory illness diagnostic app will be introduced on Health Teams' aged care monitoring platform in the second quarter of the year
Scipher Medicine’s blood test shows the benefits of precision medicine in rheumatoid arthritis
patients whose treatment was guided by PrismRA had three times better clinical responses compared to patients that didn’t. The results of Scipher’s study were published in Expert Review of Molecular Diagnostics.
Want to know more about diagnostics? Contact us at info@centivis.com